Details for New Drug Application (NDA): 217957
✉ Email this page to a colleague
The generic ingredient in LEUPROLIDE ACETATE is leuprolide acetate. There are twenty-two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 217957
Tradename: | LEUPROLIDE ACETATE |
Applicant: | Ubi |
Ingredient: | leuprolide acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 217957
Suppliers and Packaging for NDA: 217957
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEUPROLIDE ACETATE | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 217957 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-2106 | 0121-2106-02 | 1 KIT in 1 CARTON (0121-2106-02) * 1 VIAL, MULTI-DOSE in 1 CARTON (0121-1053-02) / 2.8 mL in 1 VIAL, MULTI-DOSE * 1 mL in 1 PACKET (0121-2105-01) |
LEUPROLIDE ACETATE | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 217957 | ANDA | UBI Pharma Inc. | 72843-591 | 72843-591-99 | 1 KIT in 1 CARTON (72843-591-99) * 1 VIAL, MULTI-DOSE in 1 CARTON (72843-590-01) / 2.8 mL in 1 VIAL, MULTI-DOSE * 1 mL in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;SUBCUTANEOUS | Strength | 14MG/2.8ML (1MG/0.2ML) | ||||
Approval Date: | Oct 17, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription